首页> 外文期刊>Pharmaceutical statistics. >Block response-adaptive randomization in clinical trials with binary endpoints
【24h】

Block response-adaptive randomization in clinical trials with binary endpoints

机译:具有二值终点的临床试验中的块响应自适应随机

获取原文
获取原文并翻译 | 示例
           

摘要

In a clinical trial, response-adaptive randomization (RAR) uses accumulating data to weigh the randomization of remaining patients in favour of the better performing treatment. The aim is to reduce the number of failures within the trial. However, many well-known RAR designs, in particular, the randomized play-the-winner-rule (RPWR), have a highly myopic structure which has sometimes led to unfortunate randomization sequences when used in practice.This paper introduces random permuted blocks into two RAR designs, the RPWR and sequential maximum likelihood estimation, for trials with a binary endpoint. Allocation ratios within each block are restricted to be one of 1:1, 2:1 or 3:1, preventing unfortunate randomization sequences. Exact calculations are performed to determine error rates and expected number of failures across a range of trial scenarios. The results presented show that when compared with equal allocation, block RAR designs give similar reductions in the expected number of failures to their unmodified counterparts. The reductions are typically modest under the alternative hypothesis but become more impressive if the treatment effect exceeds the clinically relevant difference.
机译:在一项临床试验中,响应自适应随机(RAR)使用累积数据来权衡其余患者的随机性,以支持效果更好的治疗。目的是减少试验中的失败次数。但是,许多著名的RAR设计(特别是随机赢家规则(RPWR))具有高度近视的结构,在实际使用中有时会导致不幸的随机序列。两种RAR设计,即RPWR和顺序最大似然估计,适用于具有二进制端点的试验。每个块内的分配比率被限制为1:1、2:1或3:1之一,从而防止了不幸的随机序列。执行精确的计算以确定在各种试验情况下的错误率和预期的失败数量。给出的结果表明,与同等分配相比,块RAR设计与未修改的同类产品相比,预期的故障数量有所减少。在替代假设下,减少幅度通常不大,但如果治疗效果超过临床相关差异,则减少幅度会更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号